cancer

When it comes to cancer, one cannot overestimate the importance of early detection. Especially when it comes to colorectal and endometrial cancer that even big pharma companies don’t have a good track record at treating. At the end of last year, Merck (NYSE: MRK) provided a non-...

In September, Biden unveiled a $240 million investment to combat cancer, augmenting the administration’s “Cancer Moonshot”, an initiative with an array of new health resources.  The funding, allocated through the recently established Advanced Research Projects Agency for...

This article was originally published by the National Organization for the Reform of Marijuana Laws (NORML) and appears here with permission. Nearly a quarter of Canadian cancer survivors acknowledge consuming cannabis as a sleep aid, according to data published in the Journal of Cancer...

In a recent development, the American Cancer Society has widened its lung cancer screening guidelines. This change could potentially result in an additional five million U.S. adults being screened each year. What Happened: As reported by Fortune, the American Cancer Society has revised its lung...

Merck & Company, Inc. (NYSE: MRK) and Japan's Daiichi Sankyo Co. Ltd. (OTC: DSKYF) entered into a global development and commercialization agreement. The companies are developing three of Daiichi Sankyo's DXd antibody-drug conjugate (ADC) candidates for patients...

Shares of Guardant Health Inc (NASDAQ: GH) climbed during the premarket trading session and morning on Wednesday. Proprietary industry checks suggested the company could sustain around 20% growth for “a number of years,” given its strong position in profiling, according to...

This story was first published on the Benzinga India portal. It’s not uncommon to see headlines about large pharmaceutical companies being sued in the U.S. — after all, the healthcare industry walks the tightrope between profit and saving lives. However, few may have expected India...

On Friday, Tesla CEO Elon Musk reacted after WHO said aspartame — a key ingredient in Diet Coke — could potentially cause cancer. What Happened: "I'd be dead long ago if aspartame was dangerous," the billionaire wrote on his social media platform Twitter.  See Also: Elon Musk Laughs As Mark...

An artificial intelligence (AI) tool, the Cryosection Histopathology Assessment and Review Machine (CHARM), is showing promise in aiding doctors in the fight against aggressive brain tumors. CHARM can quickly identify the genetic profile of a glioma tumor, a process that currently takes days or...

In a recent report, Bank of America identified the “Disruptive Dozen” emerging technologies that have the most potential to disrupt and revolutionize the healthcare sector over the next years. New therapy for ALS (amyotrophic lateral sclerosis) and a blood test for Alzheimer’s...

Patients across the United States are facing a critical shortage of chemotherapy drugs, specifically platinum-based generic drugs cisplatin and carboplatin, used to treat various types of cancers, Dr. Kristen Rice writes in a STAT News opinion piece. The Shortage: According to Dr. Rice, a medical...

Recent reports from two drug companies that had been conducing separate clinical trials to evaluate cancer treatments reveal that the trials were halted due to the deaths of six participants, including one child.  One of the trials had focused on assessing a potential treatment...

Key Takeaways: Junshi Biosciences reported dismal results in the first quarter, with operating income plunging nearly 60% and its net loss expanding by 37% Hopes of a big revenue boost from an oral Covid drug have been dashed, and the company may not recoup its investment in the short term By...

Shares of ImmunityBio (NASDAQ: IBRX) were down 55.1% on Thursday after management announced that FDA issued a complete response letter ("CRL") to its biologics license application ("BLA") seeking approval for the combination use of its lead pipeline candidate, Anktiva (N-...

Tesla CEO Elon Musk has been a skeptic of the COVID-19 vaccines and highly critical of Dr. Anthony Fauci, who in his previous capacity as the director of the National Institute of Allergy And Infectious Diseases, spearheaded the vaccine drive against the pandemic. It came as a surprise that...